Uterine Fibroid Treatment Devices Market

Uterine Fibroid Treatment Devices Market by Technology (Ablation, Hysterectomy, Myomectomy Laparoscopy, Microwave, Cryoablation, HIFU, MRgFUS, Myolysis, Embolization), Mode of Treatment (Invasive, Minimally Invasive, Non-Invasive) - Global Forecasts to 2020

Report Code: UC 1642 Dec, 2018, by marketsandmarkets.com

The global uterine fibroid treatment devices market is technologically diverse segment with presence of large number of players. The market offers significant growth opportunities in the next five years to major as well as new players that are aspiring to enter into this medical device segment.

A number of factors such as growing population base for uterine fibroid patients, technological advancements in the field of uterine/endometrial ablation & laparoscopic devices, sprouting number of hospitals & surgical centers, and growing awareness about minimally invasive and non-invasive procedures to treat uterine fibroids are stimulating the growth of global uterine fibroid treatment devices market. However, high cost-containment measures taken by various governments and ongoing healthcare reforms in the U.S. are some of the key factors restraining this market.

The emerging markets including China, India, Brazil, and Mexico have become attractive destinations for companies engaged in the development, manufacturing, and distribution of uterine fibroid treatment devices. A number of factors such as recent clinical success of endometrial ablation & laparoscopic surgical procedures during clinical evaluation for their application in uterine fibroid treatment, ongoing modernization & expansion of healthcare infrastructure across developing countries, and growing market penetration of product manufacturers & demand across rural regions from emerging markets are offering high growth opportunities for the players’ active in the global uterine fibroid treatment devices market.

Over the past three years, leading players of the global uterine fibroid treatment devices market have adopted new product launches, establishing new manufacturing facilities, and strategic acquisitions as its key business strategies to ensure their positive growth in this market. As of 2014, the leading players present in global uterine fibroid treatment devices market included Advanced Surgical Concepts, PLLC (U.S.), Boston Scientific Corporation (U.S.), CONMED Corporation (U.S.), CooperSurgical, Inc. (U.S.), Ethicon, Inc. (U.S.), Hologic, Inc. (U.S.), Medtronic, Plc (U.S.), Olympus Corporation (Japan), PENTAX Medical (Japan), and Stryker Corporation (U.S.), among others.

Scope of the Report

This research report categorizes tumor ablation market into the following segments and sub-segments:

Global Uterine Fibroid Treatment Devices Market, by Technology

  • Surgical Techniques
    • Hysterectomy
    • Myomectomy
  • Laparoscopic techniques
    • Laparoscopic Myomectomy
    • Myolysis
  • Ablation Techniques
    • Microwave Ablation
    • Hydrothermal Ablation
    • Cryoablation
    • Ultrasound Ablation
      • High Intensity Focused Ultrasound (HIFU)
      • MRI-guided Focused Ultrasound (MRgFUS)
    • Other Ablation Techniques (Includes light/laser, electrical, and radiofrequency ablation)
  • Embolization Techniques

Global Uterine Fibroid Treatment Devices Market, by Mode of Treatment

  • Invasive Treatment
  • Minimally Invasive Treatment
  • Non-invasive Treatment

Global Uterine Fibroid Treatment Devices Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • Italy
    • France
    • U.K.
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific (RoAPAC)
  • Rest of the World (RoW)

Table of Contents

1 Introduction
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Geographic Scope
           1.3.3 Years Considered for the Study
    1.4 Limitations
    1.5 Market Stakeholders

2 Research Methodology
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
                    2.1.2.3 Breakdown of Primaries
    2.2 Market Size Estimation
           2.2.1 Top-Down Approach
           2.2.2 Bottom-Up Approach
    2.3 Market Breakdown and Data Triangulation
    2.4 Research Assumptions

3 Executive Summary
    3.1 Introduction
    3.2 Current Scenario
    3.3 Future Outlook
    3.4 Conclusion

4 Premium Insights

5 Market Overview
    5.1 Introduction
    5.2 Market Segmentation
           5.2.1 Market, By Technology
           5.2.2 Market, By Mode of Treatment
    5.3 Market Evolution
    5.4 Market Dynamics
           5.4.1 Key Market Drivers
           5.4.2 Key Market Restraints
           5.4.3 Key Market Opportunities
           5.4.4 Key Market Challenges

6 Industry Insights
    6.1 Introduction
    6.2 Value Chain Analysis
    6.3 Industry Trends
    6.4 Porter's Five Forces Analysis
           6.4.1 Threat From New Entrants
           6.4.2 Threat From Substitutes
           6.4.3 Bargaining Power of Suppliers
           6.4.4 Bargaining Power of Buyers
           6.4.5 Intensity of Competitive Rivalry

7 Uterine Fibroid Treatment Devices Market, By Technology
    7.1 Introduction
    7.2 Surgical Techniques
           7.2.1 Hysterectomy 
           7.2.2 Myomectomy 
    7.3 Laparoscopic Techniques
           7.3.1 Laparoscopic Myomectomy 
           7.3.2 Myolysis 
    7.4 Ablation Techniques 
           7.4.1 Microwave Ablation 
           7.4.2 Hydrothermal Ablation 
           7.4.3 Cryoablation
           7.4.4 Ultrasound Ablation 
                    7.4.4.1 High-Intensity Focused Ultrasound (HIFU)  
                    7.4.4.2 MRI-Guided Focused Ultrasound (MRGFUS)
           7.4.5 Other Ablation Techniques*
    7.5 Embolization Techniques

8 Uterine Fibroid Treatment Devices Market, By Mode of Treatment
    8.1 Introduction
    8.2 Invasive Treatment 
    8.3 Minimally Invasive Treatment 
    8.4 Non-Invasive Treatment 

9 Uterine Fibroid Treatment Devices Market, By Region
    9.1 Introduction
    9.2 North America
           9.2.1 U.S.
           9.2.2 Canada
    9.3 Europe
           9.3.1 Germany
           9.3.2 Italy
           9.3.3 France
           9.3.4 U.K.
           9.3.5 Spain
           9.3.6 Rest of Europe (RoE)
    9.4 Asia-Pacific
           9.4.1 Japan
           9.4.2 China
           9.4.3 India
           9.4.4 Rest of Asia-Pacific (ROAPAC)
    9.5 Rest of the World (RoW)

10 Competitive Landscape
     10.1 Introduction
     10.2 Market Share Analysis, By Key Players (2014)
     10.3 Competitive Scenario
     10.4 Recent Developments
             10.4.1 New Products Launches and Product Enhancements
             10.4.2 Agreements, Partnerships, and Agreements
             10.4.3 Mergers and Acquisitions
             10.4.4 Geographic Expansions
             10.4.5 Other Developments

11 Compny Profiles*
     11.1 Introduction
     11.2 Advanced Surgical Concepts  
             11.2.1 Business Overview**
             11.2.2 Financial Overview
             11.2.3 Product Portfolio
             11.2.4 Recent Developments
     11.3 Boston Scientific Corporation  
     11.4 Conmed Corporation
     11.5 Coopersurgical, Inc.
     11.6 Ethicon, Inc.
     11.7 Hologic, Inc.
     11.8 Medtronic, PLC.
     11.9 Olympus Corporation
     11.10 Pentax Medical
     11.11 Stryker Corporation

12 Appendix
     12.1 Insights From Industry Experts
     12.2 Discussion Guide
     12.3 Introducing RT: Real Time Market Intelligence
     12.4 Available Customizations
     12.5 Related Reports

*Top 10 companies in the market will be covered
#Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.


Request for detailed methodology, assumptions & how numbers were triangulated.

Our USP is "Customised multi client reports"-so feel free to provide us specific interest in much greater detail..!!
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
UC 1642
Published ON
Dec, 2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Uterine Fibroid Treatment Devices Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved